Background-Obesity and diabetes mellitus are important metabolic risk factors and frequent comorbidities in heart failure with preserved ejection fraction. They contribute to myocardial diastolic dysfunction (DD) through collagen deposition or titin modification. The relative importance for myocardial DD of collagen deposition and titin modification was investigated in obese, diabetic ZSF1 rats after heart failure with preserved ejection fraction development at 20 weeks. Methods and Results-Four groups of rats (Wistar-Kyoto, n=11; lean ZSF1, n=11; obese ZSF1, n=11, and obese ZSF1 with high-fat diet, n=11) were followed up for 20 weeks with repeat metabolic, renal, and echocardiographic evaluations and hemodynamically assessed at euthanization. Myocardial collagen, collagen cross-linking, titin isoforms, and phosphorylation were also determined. Resting tension (F passive )-sarcomere length relations were obtained in small muscle strips before and after KCl-KI treatment, which unanchors titin and allows contributions of titin and extracellular matrix to F passive to be discerned. At 20 weeks, the lean ZSF1 group was hypertensive, whereas both obese ZSF1 groups were hypertensive and diabetic. Only the obese ZSF1 groups had developed heart failure with preserved ejection fraction, which was evident from increased lung weight, preserved left ventricular ejection fraction, and left ventricular DD. The underlying myocardial DD was obvious from high muscle strip stiffness, which was largely (±80%) attributable to titin hypophosphorylation. The latter occurred specifically at the S3991 site of the elastic N2Bus segment and at the S12884 site of the PEVK segment.
H eart failure with preserved ejection fraction (HFPEF) is currently observed in 50% of patients with heart failure. 1 The incidence of HFPEF relative to heart failure with reduced ejection fraction continues to rise, and its prognosis fails to improve partly because of lack of a specific HFPEF therapy. 2 
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Prevalence of comorbidities is higher in HFPEF than in heart failure with reduced ejection fraction. 3 Comorbidities, such as obesity and diabetes mellitus, are key constituents of metabolic risk and known to be associated with the progressive left ventricular (LV) remodeling and dysfunction characteristically observed in HFPEF. 4, 5 In HFPEF, body mass index has a U-shaped relation to mortality in contrast to heart failure with reduced ejection fraction where it displays an inverse relation with mortality. 6 Diabetes mellitus has long been recognized to be associated with LV diastolic dysfunction. 7 In HFPEF, heart failure with reduced ejection fraction, and aortic stenosis, diabetes mellitus worsens diastolic LV stiffness through a variety of mechanisms, such as myocardial fibrosis, advanced glycation endproduct deposition, and high cardiomyocyte stiffness. 8, 9 High cardiomyocyte stiffness was especially evident in patients with HFPEF and in patients with aortic stenosis and diabetes mellitus, was associated with hypophosphorylation of the giant cytoskeletal protein titin, 9, 10 November 2013 and corrected in vitro by administration of protein kinase A (PKA) or PKG. 9, 11 Furthermore, patients with high metabolic risk frequently experience salt-sensitive hypertension, which is like obesity associated with systemic oxidative stress. 12 To elucidate the mechanisms underlying myocardial dysfunction in metabolic risk-related HFPEF, the present study investigated (1) LV hemodynamics; (2) myocardial histology; (3) in vitro stiffness of small muscle strips; (4) cardiomyocyte stiffness, and (5) myocardial titin phosphorylation in hypertensive ZSF1 rats, which became morbidly obese and diabetic, during a 20-week period, because of the absence of satiation and unlimited access to a regular (ZSF1-obese) or high-fat diet (ZSF1-obese+HFD).
Methods
An expanded Methods section is available in the online-only Data Supplement.
Animal Model
Nine-week old male ZSF1 lean (ZSF1-Lean, n=11), ZSF1 obese (ZSF1-Obese, n=22), and Wistar-Kyoto rats (WKY, n=11) were obtained from Charles River (Barcelona, Spain) and fed with Purina Diet (#5008). After a 1-week laboratory adaptation period, animals underwent phenotypic evaluation consisting of metabolic cage studies, blood sample collection, and echocardiographic evaluation. To assess diastolic function, peak velocity of early (E) and late (A) mitral inflow signals and the ratio of E over E′ (peak velocity of early diastolic lateral mitral annular motion) were measured as an indication of LV filling pressure. 13 From this point onward, a subgroup of ZSF1 obese rats (ZSF1-Obese+HFD, n=11) was randomly allocated to receive HFD (Research Diet Inc, #D12468). Weight gain and energy intake were recorded every third day. Phenotypic evaluation was repeated at the 14th and 18th week of life. At 20 weeks, animals underwent hemodynamic evaluation under anesthesia and were subsequently euthanized with procurement of myocardial tissue samples for histological, biochemical, and biomechanical studies. Animals were kept in individually ventilated chambers in a controlled environment with a 12-h light/dark cycle at 22°C room temperature and had unlimited access to food. Investigation conformed to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH Publication no. 85-23, revised 1996) and was approved by the ethics committee of the Faculty of Medicine of Porto.
Histology and Collagen Gene Expression
Collagen volume fraction was determined by quantitative morphometry with an automated image analysis system in sections stained with collagen-specific picrosirius red. 8, 9 A sircol-based assay was performed to obtain and quantify total, soluble, and insoluble collagen, which was calculated by subtracting the amount of soluble collagen from the amount of total collagen. The degree of cross-linking was calculated as the ratio between soluble and insoluble collagen. Gene expression of collagen 1A1 and collagen 3A1 was performed using real-time polymerase chain reaction.
Force Measurements on Small Muscle Strips and Cardiomyocytes
Cardiomyocytes and muscle strips were incubated for 5 and 30 minutes, respectively, in relaxing solution supplemented with 0.2% Triton X-100 to remove all membrane structures and subsequently attached between a force transducer and length motor. Resting tension (F passive ) was recorded between 1.9 and 2.3 μm sarcomere length (SL). F passive of cardiomyocytes was measured before and after PKG incubation. In muscle strips, thick and thin filaments were extracted by immersing the preparation in relaxing solution containing 0.6 mol/L KCl (45 minutes at 20°C) followed by relaxing solution containing 1.0 mol/L KI (45 minutes at 20°C). After the extraction procedure, the muscle bundles were stretched again and the passive force remaining after KCl/KI treatment was assumed to be extracellular matrix (E-matrix) based. Titin-based passive force was determined as total passive force minus E-matrix-based passive force. 14 
Titin Analysis

Titin Isoform Separation
Homogenized myocardial samples were analyzed by 1.8% SDS-PAGE. Protein bands were visualized by Coomassie blue or SYPRO Ruby, scanned, and analyzed densitometrically. 15, 16 Titin Phosphorylation Assays After 1.8% SDS-PAGE, gels were stained with Pro-Q Diamond for 1 hour and subsequently with Sypro Ruby overnight. Phosphorylation signals on Pro-Q Diamond-stained gels were indexed to Sypro Rubystained titin signals. 9, 10, 15, 16 Titin/Phosphotitin Immunoblots SDS-PAGE (1.8%) and Western blot were performed to measure site-specific phosphorylation and expression of titin using custommade, affinity-purified, phosphosite-specific antibodies against phospho-S3991 (N2Bus), phospho-S12742 (PEVK), and phospho-S12884 (PEVK; positions in mouse [Mus musculus] titin according to UniProtKB identifier A2ASS6), and antibodies recognizing the corresponding nonphosphorylated sequence around these sites. 16 
Statistical Analysis
Groups were compared by 2-way repeated measures ANOVA whenever serial acquisitions were obtained for the same animal, and by 1-way ANOVA for single acquisitions. Pressure-volume loop analysis was analyzed using LabChart 7 Pro v7.3.1. Values are given as mean±SEM. A 2-tailed test with a P value of <0.05 was considered significant. Single comparisons were assessed by an unpaired Student t test. Bonferroni-adjusted t tests were used subsequently for multiple comparisons after repeated measures ANOVA. Statistical analysis was performed with SPSS (version 15.0; SPSS Inc, Chicago, IL).
Results
Cardiometabolic Risk in Obese ZSF1 Rats
ZSF1-Obese and ZSF1-Obese+HFD rats had higher weight gain at 20 weeks ( Figure 1A ). Energy intake was initially also higher in these animals but leveled off at 20 weeks ( Figure 1A ). In both obese groups, glycemia levels, glucose tolerance, and insulin resistance were higher ( Figure 1B ; Tables 1 and 2) . Hyperglycemia caused glycosuria, increased urine output, and compensatory water intake. Proteinuria suggested presence of diabetic nephropathy, despite preserved creatinine clearance and plasma protein levels (Tables 1 and 2) .
Echocardiography, Hemodynamics, and Morphometrics
Serial echocardiographic studies at 10, 14, and 18 weeks demonstrated normal systolic function in all groups (Figure 2A Tables 3 and 4 ), which progressively developed diastolic LV dysfunction, evident from a restrictive LV inflow signal, higher E/E′, and increased left atrial area at 14 and 18 weeks ( Figure 2B ; Tables 3 and 4) .
At 20 weeks, hemodynamic evaluation confirmed normal LV systolic performance, evident from LV ejection fraction, LV dP/dt max , and end-systolic pressure-volume relationship E ES I (slope of linear end-systolic pressure-volume relationship for indexed volumes; Figure 2C ; Table 5 ). Diastolic LV dysfunction was again evident from a prolonged τ, elevated LV end-diastolic pressure, an upward shift of the LV diastolic pressure-volume relationship and a higher LV diastolic chamber stiffness constant (β) ( Figure 2C ; Table 5 ).
At euthanization, lung and heart weights were increased in both obese groups ( Figure 3A ; Table 6 ). There was evidence of visceral adiposity with more perirenal and perigonadal fat ( Table 6 ).
Histology
Cardiomyocyte hypertrophy was confirmed histologically in both ZSF1-Obese groups ( Figure 3B ). Collagen volume fraction, collagen cross-linking, procollagen carboxyl-terminal proteinase type I (PCP), and procollagen carboxyl-terminal proteinase type I enhancer were similar in all groups (Figure 4) . In line with these findings, the relative mRNA expression of collagen 1A1 and collagen 3A3 was also similar among all groups ( Figure 4 ). No significant differences of Lysyl oxidase expression were observed between all groups 
F passive in Small Muscle Strips and Cardiomyocytes
The relative contributions of collagen and titin were determined in small muscle strips ( Figure 5 ). F passive -SL relations were constructed for SL ranging from 1.9 to 2.3 μm. F passive was higher in both obese groups from a SL of 2.075 μm onward ( Figure 5A ). To discern the contribution of E-matrix, F passive -SL relations were also constructed after extraction with KCl/KI ( Figure 5B ). The contribution of titin was calculated by subtracting E-matrix-based F passive from total F passive at each SL ( Figure 5C ). F passive attributable to E-matrix and titin was higher in both obese groups from a SL of 2.175 and 2.025 μm onward, respectively. At the upper limit of the physiological SL range (2.2 μm), titin accounted for 82% and 78% of F passive in ZSF1-Obese and ZSF1-Obese+HFD groups, respectively. F passive -SL relations of isolated skinned cardiomyocytes were steeper in ZSF1-Obese and ZSF1-Obese+HFD ( Figure 5D ). Incubation with PKGα returned the F passive -SL relations to control levels ( Figure 5D ). No significant differences of active tension were observed between groups in single skinned small strips and skinned cardiomyocytes. 
Titin Hypophosphorylation
N2B titin isoform expression relative to WKY was similar in all groups (WKY, 100±9.4%; ZSF1-Lean, 100.5±9.1%; ZSF1-Obese, 95.03±9.6%; and ZSF1-Obese+HFD, 71.58±11.4%), but titin phosphorylation decreased by 67% and 82% in ZSF1-Obese and ZSF1-Obese+HFD rats, respectively ( Figure 6A ). Ex vivo phosphorylation by PKG significantly increased all-titin phosphorylation in ZSF1-Obese and ZSF1-Obese+HFD, up to the level measured in WKY and ZSF1-Lean ( Figure 6B ). Using affinity-purified phosphospecific antibodies, we assessed phosphorylation status by Western blot at a conserved serine within the N2Bus segment (S3991 of full-length mouse titin) and at 2 conserved serines within the PEVK segment (S12742 and S12884; Figure 6C-6E ). In the obese groups, significant hypophosphorylation was observed at the phospho-N2Bus S3991 site and at the phospho-PEVK S12884 site but comparable phosphorylation at the phospho-PEVK S12742 site. Protein loading was checked by a sequence-specific antibody that corresponded to the phosphospecific antibody. Values are mean±SEM (n=6, each group). CI indicates cardiac index; dLVPW, left ventricular posterior wall measured in diastole; E/A, ratio between peak E and A waves of pulsed-wave Doppler mitral flow velocity; E/E′, ratio between peak E wave velocity of pulsed-wave Doppler mitral flow and peak E′ wave velocity of tissue Doppler at the lateral mitral annulus; EDVI, end-diastolic volume indexed for body surface area; EF, ejection fraction; FS, fractional shortening; HR, heart rate; LAA, left atrial area; LV, left ventricular; MPI, myocardial performance or Tei index; S, peak systolic tissue Doppler velocity; and WKY, Wistar-Kyoto rats.
*P<0.05 vs 10th wk; and †P<0.05 vs WKY. 
Discussion
The present study identified cardiac titin hypophosphorylation to be associated with high myocardial stiffness and HFPEF in an obese ZSF1 rat model with high metabolic risk.
Metabolic Risk-Related HFPEF Model
At the time of euthanization at 20 weeks, high metabolic risk was evident clearly in the obese ZSF1 rats fed either regular diet or high-fat diet. Compared with lean ZSF1 rats or WKY rats, obese ZSF1 rats showed many features of high metabolic risk such as visceral obesity evident from elevated perirenal and perigonadal fat, insulin resistance, hyperglycemia, and physical inactivity evident from striated muscle wasting. Arterial blood pressure was elevated in both obese and lean ZSF1 rats. At the time of euthanization, HFPEF was, however, only present in the obese ZSF1 rats, and high metabolic risk, therefore, seemed to be a prerequisite in this model for HFPEF development. As such, the current model differs from previous experimental HFPEF models, which largely disregarded metabolic risk as they were performed in old, hypertensive dogs 15, 16 or in Dahl salt-sensitive hypertensive rats. 17 The current model, however, closely resembles clinical HFPEF where metabolic risk is highly prevalent as evident from numerous HFPEF registries or large outcome trials. 3, 18, 19 The HFPEF presentation observed in this metabolic risk model also shares characteristic features with clinical HFPEF presentation. After 18 weeks, during closed chest echocardiographic evaluation, the E/E′ ratio was diagnostic of diastolic LV dysfunction 20 (ZSF1-Obese, 17.2±0.8; ZSF1-Obese+HFD, 15.8±1.1). At euthanization, lung weight was 60% higher in obese animals. The latter probably resulted from episodes of pulmonary edema occurring during physical activity. A similar situation occurs in patients with HFPEF who frequently have moderate abnormalities in diastolic LV function at rest but striking elevations of LV filling pressure during exercise 21, 22 because of a steep diastolic LV pressure-volume relation. 23 Steep diastolic LV pressure-volume and myocardial F passive -length relations were also present in the ZSF1 obese rats. The limited elevation of LV end-diastolic pressure in ZSF1 obese rats during open chest hemodynamic evaluation probably resulted from a reverse effect: thoracotomy and anesthesia reduced venous return to the heart, which led to a prompt fall in LV filling pressures because of steep diastolic LV pressure-volume and myocardial F passive -length relations. Apart from elevated E/E′, high diastolic LV chamber stiffness, and high myocardial stiffness, obese ZSF1 rats also had other evidence of diastolic LV dysfunction such as progressive LA enlargement and a significant increase in τ. The latter could, however, also be partially accounted for by the higher systolic arterial pressure in ZSF1-obese rats. Systolic LV function in the ZSF1 obese rats closely resembled systolic LV function of patients with HFPEF 24 as global indices of LV systolic performance (LV dP/dt max , LV ejection fraction, and E ES ) were all preserved. In ZSF1 obese rats, E ES was even higher than in control WKY rats because of a steep end-systolic LV pressure-volume relation. The simultaneous presence of steep end-systolic and end-diastolic LV pressure-volume relations forces the left ventricle to function as a fixed stroke volume pump and explains the swings from pulmonary edema to low output frequently observed in patients with HFPEF. 25 Titin Versus E-Matrix ZSF1-Obese rats had a steeper myocardial F passive -SL relation ( Figure 5A ). After extraction of the cardiac muscle strips with KCl/KI, which depolymerized thick and thin filaments thereby leaving titin unanchored, the contribution of the E-matrix to myocardial F passive became evident ( Figure 5B ). Subsequently, the contribution of titin could be calculated by subtracting the contribution of the E-matrix from the measured F passive at each SL ( Figure 5C ). For SLs ranging from 2.0 to 2.2 μm, the contribution of titin greatly exceeded the contribution of the E-matrix. At 2.0 μm, the contribution of titin was 6.8 and 9.3× larger than of E-matrix for ZSF1-obese and ZSF1-obese+HFD rats. At 2.2 μm, the contribution of titin was still 4.6 and 3.6× larger. SLs ranging from 2.0 to 2.2 μm covered the physiological range of LV filling pressures (from 5 to 40 mm Hg). Using a thick wall ellipsoid model of the LV and the measured LV end-diastolic pressure of 5 mm Hg (Table 5 ; WKY rats), the calculated LV end-diastolic wall stress (1.25 kN/m 2 ) corresponded with measured F passive (1.26 kN/m 2 ) at a 2.0 μm SL. Similarly, after adjusting the values of LV end-diastolic volume index and diastolic LV posterior wall thickness for a 2.2 μm SL and substituting LV end-diastolic wall stress by the measured F passive at 2.2 μm SL (13.70 kN/m 2 in ZSF1-obese+HFD), the same thick wall ellipsoid model yielded a LV end-diastolic pressure of 41 mm Hg. Hence, up to filling pressures exceeding 40 mm Hg, titin accounted for 82% and 78% of F passive in ZSF1-obese and ZSF1-obese+HFD rats, respectively. High titin-based stiffness is, therefore, the main contributor to high myocardial stiffness and likely also to HFPEF development in this metabolic riskrelated rat HFPEF model. The importance of intrinsic cardiomyocyte stiffness was also evident from the F passive -SL relation of isolated skinned cardiomyocytes ( Figure 5D ), which was steeper and shifted upward in both ZSF1-obese and ZSF1-obese+HFD rats. Furthermore, in vitro administration of PKG to the isolated cardiomyocytes corrected the F passive -SL relations. This in vitro reversibility suggests the high F passive of cardiomyocytes of obese ZSF1 rats to result more from altered phosphorylation status than from structural changes of titin, such as isoform shifts or oxidative damage. In vitro reversibility of high F passive was also observed in the ZSF1-obese+HFD rats, which were exposed to the highest systemic oxidative stress.
Limited involvement of the E-matrix in the high F passive of the obese ZSF1 rats was evident also from histological/biochemical analyses of myocardial tissue. Global myocardial collagen volume fraction, collagen cross-linking, collagen 1A1 or collagen 3A3 gene expression, and procollagen carboxyl-terminal proteinase type I or procollagen carboxyl-terminal proteinase type I enhancer activity were unaltered in the obese ZSF1 rats (Figure 4 ). Despite these findings, there was a small increase in myocardial F passive attributable to the E-matrix at SL >2.175 μm in ZSF1-obese and ZSF1-obese+HFD rats ( Figure 5B ). This increase could have resulted from subtle alterations in endomysial collagen, which remained undetected by histological analysis or by components of the E-matrix other than collagen.
Titin Hypophosphorylation
Titin stiffness can be modulated mainly through isoform shifts or alterations of the phosphorylation status. In patients presenting with eccentric LV remodeling after myocardial infarction or with dilated cardiomyopathy, a titin isoform shift from the stiff N2B to the compliant N2BA isoform has been reported. 26, 27 In patients with concentric LV remodeling related to HFPEF or aortic stenosis, most studies failed to observe a major shift in titin isoform expression. 9, 28 Rat hearts predominantly express N2B titin isoform, the proportion of which remained unaffected in the present study by the concentric LV remodeling observed in lean and obese ZSF1 rats.
As previously observed in patients with HFPEF, patients with aortic stenosis and type 2 diabetes mellitus, and old hypertensive dogs with HFPEF, 9, 10, 16 overall N2B titin isoform phosphorylation was greatly reduced in the obese ZSF1 rats, especially when exposed to HFD ( Figure 6A ). Using site-specific antibodies, the S3991 site and the S12884 of the N2Bus and PEVK segments of titin were identified as being hypophosphorylated ( Figure 6C and 6E). The S3991 site can be phosphorylated by both PKA and ERK2 (extracellular-regulated kinase 2) 29, 30 and recently was also shown to be hypophosphorylated in old hypertensive HFPEF dogs. 16 Phosphorylation of the S12742 site of the PEVK segment was unaltered in contrast to old hypertensive HFPEF dogs where it was hyperphosphorylated. 16 Increased phosphorylation of the N2Bus segment is reported after PKA or PKG administration [31] [32] [33] [34] [35] and shown to lower F passive , whereas increased phosphorylation of the S12742-PEVK occurs after PKCα administration and raises F passive . 36 Both PKCα and calmodulin-dependent protein kinase II can phosphorylate the S12884-PEVK site. Phosphorylation of the S12884-PEVK site Figure 6 . Total and site-specific phosphorylation of titin N2Bus/ PEVK segments. A, Total titin phosphorylation in all groups. B, Effect of ex vivo phosphorylation by protein kinase G (PKG) on alltitin phosphorylation in all groups. C, Titin phosphorylation at S3991 site in all groups. D, Titin phosphorylation at S12742 site in all groups. E, Titin phosphorylation at S12884 in all groups (*P<0.05). ZSF1 lean (ZSF1-Lean, n=5), ZSF1 obese (ZSF1-Obese, n=10), and Wistar-Kyoto rats (WKY, n=5).
by calmodulin-dependent protein kinase II leads to a reduction of F passive . 37 The elevated F passive observed in the present study in the obese ZSF1 rats is consistent with the observed hypophosphorylation of the S3991 site within the N2Bus segment and the observed hypopohosphorylation of the S12884 site within the PEVK segment.
Conclusions
Obese ZSF1 rats with a high metabolic risk profile developed HFPEF at 20 weeks. The diagnosis of HFPEF was based on lung congestion, preserved global LV systolic function, and diastolic LV dysfunction. The latter was evident from elevated E/E′, LA enlargement, high LV diastolic chamber stiffness, and high myocardial stiffness. High myocardial stiffness was largely (±80%) attributable to high cardiomyocyte stiffness, which resulted from hypophosphorylation of titin. 
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